Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M102081200 on April 19, 2001

J. Biol. Chem., Vol. 276, Issue 26, 24360-24364, June 29, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/26/24360    most recent
M102081200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komuro, I.
Right arrow Articles by Akagawa, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komuro, I.
Right arrow Articles by Akagawa, K. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Human Alveolar Macrophages and Granulocyte-macrophage Colony-stimulating Factor-induced Monocyte-derived Macrophages Are Resistant to H2O2 via Their High Basal and Inducible Levels of Catalase Activity*

Iwao KomuroDagger §, Naoto KeichoDagger , Aikichi Iwamoto§, and Kiyoko S. AkagawaDagger ||

From the Dagger  Department of Immunology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, the § Division of Infectious Diseases, the Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Shiroganedai 4-6-1, Minato-ku, Tokyo 108-8639, and the  Department of Respiratory Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan

Received for publication, March 8, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human alveolar macrophages (A-MPhi ) and macrophages (MPhi ) generated from human monocytes under the influence of granulocyte-macrophage colony-stimulating factors (GM-MPhi ) express high levels of catalase activity and are highly resistant to H2O2. In contrast, MPhi generated from monocytes by macrophage colony-stimulating factors (M-MPhi ) express low catalase activity and are about 50-fold more sensitive to H2O2 than GM-MPhi or A-MPhi . Both A-MPhi and GM-MPhi but not M-MPhi can induce catalase expression in both protein and mRNA levels when stimulated with H2O2 or zymosan. M-MPhi but not GM-MPhi produce a large amount of H2O2 in response to zymosan or heat-killed Staphylococcus aureus. These findings indicate that GM-MPhi and A-MPhi but not M-MPhi are strong scavengers of H2O2 via the high basal level of catalase activity and a marked ability of catalase induction and that catalase activity of MPhi is regulated by colony-stimulating factors during differentiation.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human alveolar macrophages (A-MPhi )1 can survive for a long duration (1-4) to exposure to not only chemical pollutants and exogenous oxidants but also inflammatory mediators and endogenously generated reactive oxygen species (ROS) and play important roles in phagocytosis-mediated host defense against microbial infection via the airway (5, 6). Superoxide dismutase, catalase, and glutathione are the main cellular ROS-degrading enzyme systems; superoxide dismutase converts superoxide radical (O&cjs1138;2) into H2O2, which is metabolized by catalase and glutathione peroxidase. Previous studies indicated that these enzymes are abundant in A-MPhi (7-9). However, the mechanism to maintain high antioxidant activities in A-MPhi has not been understood because of its heterogeneity and lack of availability to study.

Colony-stimulating factors (CSFs) such as granulocyte-macrophage CSF (GM-CSF) and macrophage-CSF (M-CSF) play important roles in survival and differentiation of monocytes/MPhi . Previously, we reported that CSFs such as GM-CSF and M-CSF stimulate MPhi generation from human monocytes, but GM-CSF-induced MPhi (GM-MPhi ) and M-CSF-induced MPhi (M-MPhi ), however, are distinct in their morphology, cell surface antigen expression (c-fms, CD14, CD71, and 710F), and sensitivity to human immunodeficiency virus, type I (HIV-I) infection (10-14). Other studies also demonstrated that human monocyte-derived GM-MPhi and M-MPhi are distinct in their expression of CD14, integrin, and antibody-dependent cellular cytotoxicity activity (15-18). Numerous studies show that the phenotype of human A-MPhi closely resembles that of GM-MPhi in morphology (fried egg-like shape) (19), the expression of cell surface antigens (c-fmslow, CD14low, CD71+, and 710F+) (11, 13, 20-22), and function (resistance to MPhi -tropic HIV-I infection) (12, 23). In contrast, M-MPhi are elongated and spindle-shaped, express c-fmshigh and CD14high, which are similar to the phenotype of anaerobic peritoneal MPhi (11, 20, 21, 24), and are sensitive to MPhi -tropic HIV-I infection (12). These findings suggest that CSF is one of the critical factors in the determination of phenotypical characteristics of tissue MPhi in the human system, and CSF-induced monocyte-derived MPhi are available to analyze tissue MPhi .

In the present study, we investigated whether the antioxidant states of GM-MPhi are at similar levels to those of A-MPhi by assessment of H2O2 sensitivity and catalase activity. We found that GM-MPhi express high basal and inducible levels of catalase activity, are highly resistant to H2O2 compared with M-MPhi , and inhibit H2O2 production when stimulated with microbial stimulants. We also observed that catalase activity and sensitivity to H2O2 in GM-MPhi are at similar levels to those in A-MPhi . These findings suggest that GM-CSF but not M-CSF induces a strong antioxidant system in human tissue MPhi during the differentiation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Medium-- RPMI 1640 medium (Nissui Seiyaku Co., Ltd., Tokyo, Japan) was supplemented with 3 mg/ml glutamine (Sigma), 100 units/ml penicillin G potassium (Banyu Seiyaku Co., Ltd., Tokyo, Japan), 100 µg/ml streptomycin (Meiji Seika Co., Ltd., Tokyo, Japan), 10% of autoclaved NaHCO3, and finally 10% heat-inactivated fetal calf serum (Z. L. Bockneck Laboratories Inc., Ontario, Canada). Fetal calf serum and distilled water were shown to contain 3 pg and less than 1 pg of lipopolysaccaride per ml by the Limullus amebocyte lysate test, respectively.

Cytokines-- Recombinant human GM-CSF (1 × 108 units/mg) and recombinant human M-CSF (2 × 108 units/mg) were kindly provided by Schering-Plough Japan (Osaka, Japan) and Morinaga Milk Industry Co., Ltd. (Tokyo, Japan), respectively.

Preparation and Culture of Macrophages-- Peripheral blood mononuclear cells were obtained from venous blood drawn from normal healthy volunteers as described previously (12, 13). Briefly, peripheral blood mononuclear cells were isolated by centrifugation on a Ficoll-Metrizoate density gradient (Lymphoprep; Nycomed, Oslo, Norway) and then placed into monocyte-isolating plates (MSP plates; Japan Immunoresearch Laboratories, Co., Ltd., Takasaki, Japan) for 2 h at 37 °C in a humidified 5% CO2 atmosphere (CO2 incubator). More than 97% of the recovered cells were judged to be monocytes based on morphology, nonspecific esterase staining (cells were stained using a kit for alpha -naphthyl butyrate esterase), CD14 positivity, and their ability to phagocytize latex particles. Monocytes (2.5 × 105 per ml or 5 × 105 per 2 ml in 12- or 6-well tissue culture plates, respectively) were then cultured with a optimal concentration of GM-CSF (500 units/ml) or M-CSF (104 units/ml) for 7 days at 37 °C in a CO2 incubator. During the culture, monocytes underwent morphologic changes characteristic of monocytes to MPhi differentiation such as an increase in their size and adherence.

Human A-MPhi (2.5 × 105 per ml or 5 × 105 per 2 ml in 12- or 6-well tissue culture plates, respectively) were obtained from healthy volunteers (non-smokers without pathogenesis) by bronchoalveolar lavage (4, 25). All volunteers agreed with a document to permit the use of A-MPhi in part of this study, as informed consent. A-MPhi were incubated in plastic dishes for 1 h at 37 °C in a CO2 incubator, and non-adherent cells were removed by repeated washing.

Assessment of Cell Number and Viability-- Cell viability was assessed by trypan blue dye exclusion. The number of adherent monocytes and monocyte-derived MPhi s was determined by the method described previously by Nakagawara and Nathan (26). Briefly, cultures were depleted of medium by gentle aspiration and then replenished with 1% (w/v) cetyltrimethyl ammonium bromide (Cetavlon; Wako Pure Chemical Industries, Ltd., Osaka, Japan) in 0.1 M citric acid with 0.05% (w/v) naphthol blue black (Sigma) at room temperature for 3 min. This treatment readily lysed the adherent cells and liberated stained intact nuclei, which were then counted using a TATAI hemocytometer (American Optical).

Measurement of Catalase Activity-- Intracellular and extracellular catalase activity was measured according to the method described by Aebi (27). Briefly, MPhi were cultured in the phenol red-free medium (Life Technologies, Inc.) supplemented with the indicated concentrations of M-CSF or GM-CSF. Culture supernatants were harvested at 48 h for the measurement of extracellular catalase. To measure the intracellular catalase, cell lysates were prepared with a specific lysis buffer (10 mmol/liter EDTA, 2% Triton-X, 0.05% deoxycholic acid in phosphate-buffered saline, pH 7.4) and then diluted with 50 mmol/liter phosphate buffer (pH 7.0). 2 ml of the diluted sample was dispensed into a quartz cube, followed by 1 ml of 30 mmol/liter H2O2 in phosphate buffer (pH 7.0). Catalase activity was measured by the consumption of H2O2 at 240 nm in a spectrophotometer (Graphicord UV-240; Shimadzu Co., Kyoto, Japan) at 20 °C. The slope was converted into catalase activity units based on the standard curve of purified human erythrocyte catalase (HEC, 5 × 104 units/mg, Lot. number 643793; Calbiochem-Novabiochem). The activity is shown as milliunits/ml per well (2.5 × 105 cells) or units per mg of protein using a protein assay kit (Bio-Rad Laboratories, Hercules, CA).

Isolation of RNA and Northern Blot Analysis-- Isolation of total RNA and Northern blot analysis were performed as described previously (13). Briefly, cells were lysed with denaturing solution containing 4 mol/liter guanidine thiocyanate, 25 mmol/liter sodium citrate (pH 7.0), 0.5% sarcosyl, and 0.1 mol/liter 2-mercaptoethanol. After transfer to a polypropylene tube, total RNA was extracted by sequential addition of 2 mol/liter sodium acetate (pH 4.0), water-saturated phenol, and chloroform-isoamylalcohol (49:1), followed by centrifugation at 10,000 rpm for 20 min at 4 °C and then precipitated with isopropanol and ethanol. Total RNA (10 µg/lane) was size-fractionated by electrophoresis after denaturation with 6% (v/v) deionized glyoxal and 50% (v/v) dimethyl sulfoxide and then transferred to a nylon membrane (Pall BioSupport, East Hills, NY). After cross-linking on the membrane under UV irradiation and boiling in 80 mmol/liter Tris-HCl (pH 8.0) for 5 min, the membrane was prehybridized in prehybridization buffer (5 Prime right-arrow 3 Prime, Inc., Boulder, CO) and 50% formamide at 42 °C for 3 h. Hybridization for catalase or beta -actin transcript was performed in hybridization buffer containing a human catalase cDNA probe or beta -actin cDNA probe as a standard. All probes were labeled using a multiprime DNA labeling system with [alpha -32P]dCTP (PerkinElmer Life Sciences). Blots were washed at 37 °C in 2× SSC and 0.1% SDS, 45 °C in 2× SSC, 0.2× SSC in 0.1% SDS for 30 min each and then analyzed using a Fuji BAS 2000 bioimage analyzer (Fuji Photo Film Co., Ltd., Tokyo, Japan).

Western Blot Analysis-- Cell lysates were prepared with sample buffer containing 4% SDS, 62.5 mmol/liter Tris-HCl (pH 6.8), 10% glycerol, 100 mmol/liter dithiothreitol and 0.005% bromphenol blue. Cell lysates (25 µg protein/lane) were separated by 10% SDS-polyacrylamide gel electrophoresis and then transferred to an Immobilon P membrane (Millipore Corp., Bedford, MA) using a semidry electroblotting system (Bio CRAFT BE300, BIO CRAFT Corp., Tokyo, Japan). The membrane was blocked with non-fat milk (BlockAce; Dainippon Medical Corp., Osaka, Japan) at 4 °C overnight to avoid nonspecific binding and then incubated at 4 °C overnight with 1 µg/ml of rabbit anti-HEC antibody (Athens Research and Technology, Inc., Athens, GA) or normal rabbit IgG. After four washes in Tris-buffered saline (10 mmol/liter Tris-HCl, pH 8.0, 150 mmol/liter NaCl) supplemented with 0.1% Tween 20, the membrane was incubated at room temperature for 1 h with horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology). After four washes with Tris-buffered saline supplemented with 0.1% Tween 20, the specific bands were visualized with Amersham Pharmacia Biotech ECL reagent on Hyper ECL film (Amersham Pharmacia Biotech).

Measurement of H2O2 Production-- Cellular release of H2O2 was detected by the semiautomated microassay reported by De la Harpe and Nathan (28). In brief, cultured MPhi (5 × 104 per 100 µl in 96-well flat-bottom tissue culture plates) were rinsed with phosphate-buffered saline, 100 µl of assay mixture (30 mmol/liter scopoletin (Sigma), 1 mmol/liter NaN3, 1 purpurogallin unit/ml horseradish peroxidase (Sigma) in Krebs-Ringer phosphate buffer (145 mmol/liter NaCl, 4.86 mmol/liter KCl, 0.54 mmol/liter CaCl2, 1.22 mmol/liter MgSO4, 5.7 mmol/liter sodium phosphate) with 5.5 mmol/liter glucose) was dispensed into the wells. Immediately, after the addition of stimuli (zymosan or heat-killed Staphylococcus aureus), the plate was placed in a fluorometer (Titertek Fluoroskan II; Flow Laboratories Inc., McLean, VA), and fluorescence was recorded for each well (0-60 min) at 37 °C. H2O2 release was calculated from the loss of fluorescence, using the following formula: H2O2 released (in nmol) = [(E0 - W)/(C0 - W) - (E60 - W)/(C60 - W)] × S, where E0 is the initial fluorescence reading for the well, E60 is the fluorescence reading at 60 min, W is the fluorescence recorded in an empty well, C0 and C60 are the mean fluorescence readings in the cell-free control wells at 0 and 60 min, respectively, and S is the amount of scopoletin, 3 nmol, added to each well at the start of the assay.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Distinct Susceptibility of Monocyte-derived MPhi s and A-MPhi to Exogenously Added H2O2-- MPhi generated from human monocytes by CSF (M-MPhi and GM-MPhi ) and A-MPhi were cultured in the medium containing the indicated concentrations of H2O2 for 48 h and then cell viability was determined. There was a marked difference in their susceptibility to exogenously added H2O2 (Fig. 1). When M-MPhi were treated with 10 and 1 mmol/liter H2O2, 100 and 75% of the cells died, respectively, whereas almost 100% of the cells were viable in 0.1 mmol/liter H2O2. In contrast, more than 90% of GM-MPhi were viable even when treated with 10 mmol/liter H2O2. Thus, GM-MPhi were about 50-fold more resistant to H2O2 than M-MPhi . A-MPhi also showed a strong resistance to H2O2, and the level of resistance was similar to that of GM-MPhi (Fig. 1)


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Susceptibility of CSF-induced monocyte-derived MPhi s and A-MPhi to exogenously added H2O2. M-MPhi and GM-MPhi (2.5 × 105/ml/well) were cultured in medium containing M-CSF or GM-CSF, and A-MPhi were cultured in medium without CSF. The indicated concentrations of H2O2 were added and incubated for 48 h. Cell number and viability of MPhi s was assessed using Cetavlon and trypan blue dye as described under "Experimental Procedures." Values are expressed as the means of triplicate cultures ± S.D.

Intracellular and Extracellular Catalase Activities and Catalase Gene Expression in Monocyte-derived MPhi s and A-MPhi -- Because GM-MPhi and A-MPhi were markedly more resistant to H2O2 than M-MPhi , we examined the levels of cell associated- and extracellular catalase activity that catalyze H2O2 to H2O in these MPhi s. Extracellular catalase activity in the culture supernatants obtained from GM-MPhi incubated for 48 h was about 4-fold higher than that from M-MPhi (about 160 and 40 milliunits/ml/well in GM-MPhi and M-MPhi , respectively) (Fig. 2A). Culture supernatants obtained from A-MPhi also contained high extracellular catalase activity (about 160 milliunits/ml/well), and the level was similar to that of GM-MPhi (Fig. 2A). In accordance with the findings of the enzyme activity, protein levels of extracellular catalase in GM-MPhi and A-MPhi cultures were about 4-fold higher than that in M-MPhi cultures by Western blot analysis using anti-HEC antibody (Fig. 2B). Similarly, catalase activity in M-MPhi lysates at 24 h was about 1 units/mg protein, whereas those in GM-MPhi - and A-MPhi -lysates were about 5 units/mg protein. (Fig. 3A). In agreement with the enzyme activity, protein levels of catalase among these MPhi lysates were significantly different; catalase protein levels in GM-MPhi and A-MPhi lysates were higher than that in M-MPhi lysate, and the difference was about 5-fold (Fig. 3B). As the above findings suggest that expression of catalase gene is quite different between M-MPhi and GM-MPhi or A-MPhi , we examined the levels of catalase mRNA among these MPhi s at 24 h after their cultivation by Northern blot analysis. Catalase mRNA in GM-MPhi was about 5-fold higher than that in M-MPhi , which was similar to that in A-MPhi (Fig. 3C).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 2.   Activities and protein levels of extracellular catalase in monocyte-derived MPhi s and A-MPhi . M-MPhi , GM-MPhi , and A-MPhi (2.5 × 105/ml/well) were cultured for 48 h as indicated in the legend for Fig. 1. Enzyme activities of catalase in the culture medium from M-MPhi , GM-MPhi , and A-MPhi (A) are shown. Statistical analysis was performed between samples using Student's t test. N.S., not significant. Western blot analysis of catalase protein in the culture medium (25 µl/lane) of MPhi s by using anti-HEC antibody (B) is shown. Relative intensities were measured using NIH image software (photo-stimulated luminescence/mm2).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   Activities and protein levels of intracellular catalase and mRNA expression of the catalase gene in monocyte-derived MPhi s and A-MPhi . Enzyme activities (A) and protein levels (B) of cell-associated catalase from MPhi lysates (25 µg protein/lane) at 24 h of cultivation were examined as indicated in the legend for Fig. 2. N.S., not significant. C, mRNA levels of catalase and beta -actin genes were examined in total RNA preparations (10 µg/lane) from these MPhi s at 3 h of cultivation by Northern blot analysis. kb, kilobase pair.

Oxidant Stress- or Microbial Stimulant-induced Catalase Gene Expression Is High in Both GM-MPhi and A-MPhi but Low in M-MPhi -- Although there is a significant difference in basal levels of catalase activity between M-MPhi and GM-MPhi or A-MPhi , the findings cannot fully explain their distinct susceptibility to H2O2; the difference in catalase activity was 4-5-fold, whereas the difference in sensitivity to H2O2 was about 50-fold. We therefore examined whether oxidant stress triggers the augmented expression of catalase gene in monocyte-derived MPhi s. When these MPhi s were treated for 3 h with 0.1 mmol/liter H2O2, catalase mRNA in GM-MPhi was augmented up to about 3-fold, whereas that in M-MPhi did not change significantly (Fig. 4A). Next we examined whether zymosan stimulation induces catalase gene activation in these MPhi s. When MPhi s were stimulated for 3 h with 0.1 mg/ml zymosan, catalase mRNA in GM-MPhi , but not in M-MPhi , also increased about 3-fold (Fig. 4A).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 4.   Induction ability of the catalase gene and protein in CSF-induced monocyte-derived MPhi s and A-MPhi by exogenously added H2O2 or zymosan. M-MPhi and GM-MPhi were cultured in the medium containing M-CSF or GM-CSF, and A-MPhi were cultured in the medium without CSF supplemented with or without 0.1 mmol/liter H2O2 or 0.1 mg/ml zymosan. mRNA levels (10 µg/lane) of the catalase gene at 3 h (A) or the protein levels (25 µg protein/lane) at 24 h (B) were examined as indicated in the legend for Fig. 3. kb, kilobase pair.

To confirm that catalase protein was synthesized by induction of the catalase gene via oxidant stress or microbial stimulant, we conducted a Western blot analysis of catalase protein in MPhi lysates (Fig. 4B). The levels of catalase protein in lysates of GM-MPhi stimulated for 24 h with H2O2 or zymosan increased up to about 3-fold, whereas such oxidant-triggered induction of catalase protein was not observed in lysates of M-MPhi (Fig. 4B). Oxidant stress or microbial stimulant-mediated catalase induction in both gene and protein levels was also observed in A-MPhi treated with H2O2 or zymosan, and the induction level was similar to that in GM-MPhi (Fig. 4). These findings indicate that GM-MPhi and A-MPhi have a marked ability to induce catalase expression in both gene and protein levels in response to H2O2 or microbial stimulant, but M-MPhi lacks this ability.

M-MPhi Releases a Large Amount of H2O2, but GM-MPhi Inhibits H2O2 Release by Stimulation with Fungal or Bacterial Agents-- As demonstrated above, GM-MPhi and A-MPhi but not M-MPhi express high levels of catalase activity. These findings suggest the possibility that GM-MPhi , but not M-MPhi , has a marked ability to scavenge H2O2. As shown in Fig. 5, when GM-MPhi and A-MPhi were stimulated with 1 mg/ml zymosan for 60 min, M-MPhi and GM-MPhi released 0.8 ± 0.06 nM/ml H2O2 and 0.1 ± 0.02 nM/ml H2O2, respectively. Similar findings were obtained when these MPhi s were stimulated with 1 mg/ml heat-killed S. aureus; M-MPhi released 0.5 ± 0.04 nM/ml H2O2 whereas GM-MPhi released 0.1 ± 0.01 nM/ml H2O2. Both MPhi s did not produce H2O2 without stimuli. These findings suggest that M-MPhi releases a large amount of H2O2, unlike GM-MPhi , through their distinct regulation of catalase activities.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Stimulant-induced H2O2 release in M-MPhi and GM-MPhi . The assay mixture containing 1 mg/ml zymosan or 1 mg/ml heat-inactivated S. aureus was dispensed into the wells of M-MPhi and GM-MPhi . The cellular release of H2O2 was recorded for 60 min at 37 °C using a semiautomated microassay.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We showed in the present study that GM-MPhi and A-MPhi are highly resistant to H2O2 via the high basal level of catalase activity and a marked ability to express catalase in response to H2O2. About 1-10 mmol/liter H2O2, similar to levels found on expiration in the adult respiratory distress syndrome (29, 30), did not induce cell death of GM-MPhi and A-MPhi . A strong antioxidant mechanism of human A-MPhi supported by high catalase activity may help them to be long survivors in an oxidant-rich environment and contribute to lung homeostasis.

In contrast to GM-MPhi and A-MPhi , M-MPhi are sensitive to exogenous H2O2 up to about 50-fold. In accordance with the susceptibility to H2O2, M-MPhi s express lower levels of basal catalase activity and lack the ability to induce catalase gene expression in response to H2O2. M-MPhi also produced a large amount of H2O2 compared with GM-MPhi in response to microbial stimulants (see Fig. 5 and Ref. 24). These findings suggest the possibility that MPhi induced by M-CSF support oxidant-induced inflammation or H2O2-mediated bactericidal activity. In agreement with the present findings, M-CSF augments anticryptococcal activity of fluconazole in the mouse MPhi mediated by H2O2 production (31, 32).

In the present study, GM-MPhi and A-MPhi , but not M-MPhi , have a marked ability to induce catalase gene expression by exposure of low levels of H2O2 and zymosan, which can augment their protection against oxidant-rich environments. Analysis of the 5'-flanking region of the catalase gene in human hepatoma cells and bronchoepithelial cells demonstrated that several transcriptional regulation sites in response to oxidant stress exist in the promoter region (33, 34). These cells, however, express low levels of catalase activity, and hyperoxia fails to augment catalase transcript but induces transactivation of the heat shock protein 70 gene to support their survival (35-37). The present study is the first to report that MPhi s such as A-MPhi and GM-MPhi have a marked ability to induce catalase gene expression in response to oxidant stress. The precise mechanism, however, remains unknown.

A marked difference in catalase activity as one of the antioxidant systems between GM-MPhi and M-MPhi contributes to the generation of MPhi heterogeneity during the differentiation of monocytes under the influence of CSF. Previous studies demonstrated that morphology, the expression of cell surface antigens, and resistance to HIV-I infection of GM-MPhi resembled those of human A-MPhi (11, 12, 14, 19-23). In the present study, we also show that catalase activity and H2O2 sensitivity of GM-MPhi also resembled those of human A-MPhi . An important role of GM-CSF in A-MPhi function was also reported in GM-CSF or GM-CSF receptor gene knockout mice (38-42). These findings and those of the present study strongly suggest that GM-CSF plays a critical role in the development of ROS scavenging ability via catalase activity in human A-MPhi .

We demonstrated that GM-MPhi are resistant to H2O2 and a weak producer of H2O2 by bacterial and fungal stimuli via high catalase activity. In contrast, M-MPhi s produce and release a large amount of H2O2 because of their low catalase activity. We previously reported that M-MPhi has a great capacity to produce HIV-IPAR whereas GM-MPhi inhibits HIV-IPAR replication (12). Numerous studies have shown that ROS, including H2O2, trigger HIV-I replication via NF-kappa B transactivation in the HIV-I long terminal repeat promoter region (43, 44). Furthermore, a critical role of H2O2 in NF-kappa B-mediated HIV-I replication was confirmed by reduction of HIV-I replication with the scavengers, including catalase in human monocyte/MPhi lineage cells (45, 46). In some studies, exposure to bacterial products rendered MPhi highly susceptible to T lymphocyte-tropic HIV-I via production of endogenous ROS and proinflammatory cytokines (47). These findings suggest that the difference in catalase activity between M-MPhi and GM-MPhi is a critical factor in the determination of their susceptibility to HIV-I replication.

In summary, we present evidence that catalase contributes to protect human tissue MPhi from oxidant-induced cell death and control their respiratory burst, and the activity is regulated at both the protein and mRNA levels by CSF during their differentiation. GM-CSF but not M-CSF plays a critical role in the induction of a strong antioxidant mechanism. The comparison of GM-MPhi and A-MPhi with M-MPhi in response to ROS helps clarify the self-defense mechanism of MPhi against oxidant stress in vivo.

    ACKNOWLEDGEMENTS

We thank Dr. K. Onozaki Faculty of Pharmaceutical Science, Nagoya City University, Nagoya, Japan) for the human catalase cDNA probe. We also thank Professor S. Gordon (Sir William Dunn School of Pathology, University of Oxford) for critical comments and for additional help on the manuscript.

    FOOTNOTES

* This study was supported in part by grants from the Japan Health Science Foundation and the Ministry of Health and Welfare of Japan (to K. S. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Tel.: 81-3-5285-1111; Fax: 81-3-5285-1150; E-mail: akagawak@nih.go.jp.

Published, JBC Papers in Press, April 19, 2001, DOI 10.1074/jbc.M102081200

    ABBREVIATIONS

The abbreviations used are: A-MPhi , alveolar macrophages; MPhi (s), macrophage(s); CFS(s), colony-stimulating factor(s); GM-CSF, granulocyte-macrophage colony-stimulating factor, GM-MPhi , GM-CSF-induced macrophages; M-CSF, macrophage colony-stimulating factor; M-MPhi (s), M-CSF-induced macrophages; ROS, reactive oxygen species; HEC, human erythrocyte catalase; HIV-I, human immunodeficiency virus, type I.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Thomas, E. D., Ramberg, R. E., Sale, G. E., Sparkes, R. S., and Golde, D. W. (1976) Science 192, 1016-1018
2. van oud Alblas, A. B., and van Furth, R. (1979) J. Exp. Med. 149, 1504-1518
3. Marques, L. J., Teschler, H., Guzman, J., and Costabel, U. (1997) Am. J. Respir. Crit. Care Med. 156, 1700-1702
4. Nakata, K., Gotoh, H., Watanabe, J., Uetake, T., Komuro, I., Yuasa, K., Watanabe, S., Ieki, R., Sakamaki, H., Akiyama, H., Kudoh, S., Naitoh, M., Satoh, H., and Shimada, K. (1999) Blood 93, 667-673
5. Rossi, F. (1986) Biochim. Biophys. Acta 853, 65-89
6. Sibille, Y., and Reynolds, H. Y. (1990) Am. Rev. Respir. Dis. 141, 471-501
7. Zeidler, R. B., Flynn, J. A., Arnold, J. C., and Conley, N. S. (1987) Inflammation 11, 371-379
8. Duran, H. A., Giulivi, C., Boveris, A., and De Rey, B. M. (1988) Cell. Mol. Biol. 34, 507-515
9. Pietarinen, P., Raivio, K., Devlin, R. B., Crapo, J. D., Chang, L. Y., and Kinnula, V. L. (1995) Am. J. Respir. Cell Mol. Biol. 13, 434-441
10. Akagawa, K. S. (1994) Nippon Saikingaku Zasshi 49, 385-393
11. Akagawa, K. (1994) Hum. Cell 7, 116-120
12. Matsuda, S., Akagawa, K., Honda, M., Yokota, Y., Takebe, Y., and Takemori, T. (1995) AIDS Res. Hum. Retroviruses 11, 1031-1038
13. Akagawa, K. S., Takasuka, N., Nozaki, Y., Komuro, I., Azuma, M., Ueda, M., Naito, M., and Takahashi, K. (1996) Blood 88, 4029-4039
14. Akagawa, K. S. (1997) Jpn. J. Med. Mycol. 38, 209-214
15. Young, A. D., Lowe, D. L., and Clark, C. S. (1990) J. Immunol. 145, 607-615
16. De Nichilo, M. O., and Burns, G. F. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2517-2521
17. De Nichilo, M. O., and Yamada, K. M. (1996) J. Biol. Chem. 271, 11016-11022
18. Keler, T., Wallace, P. K., Vitale, L. A., Russoniello, C., Sundarapandiyan, K., Graziano, R. F., and Deo, Y. M. (2000) J. Immunol. 164, 5746-5752
19. Nakata, K., Akagawa, K. S., Fukayama, M., Hayashi, Y., Kadokura, M., and Tokunaga, T. (1991) J. Immunol. 147, 1266-1272
20. Radzun, H. J., Kreipe, H., Heidorn, K., and Parwaresch, M. R. (1988) J. Leukocyte Biol. 44, 198-204
21. Andreesen, R., Brugger, W., Scheibenbogen, C., Kreutz, M., Leser, H. G., Rehm, A., and Lohr, G. W. (1990) J. Leukocyte Biol. 47, 490-497
22. Hirata, T., Bitterman, P. B., Mornex, J. F., and Crystal, R. G. (1986) J. Immunol. 136, 1339-1345
23. Nakata, K., Weiden, M., Harkin, T., Ho, D., and Rom, W. N. (1995) Mol. Med. 1, 744-757
24. Hashimoto, S., Yamada, M., Motoyoshi, K., and Akagawa, K. S. (1997) Blood 89, 315-321
25. Goto, H., Yuasa, K., Sakamaki, H., Nakata, K., Komuro, I., Iguchi, M., Okamura, T., Ieki, R., Tanikawa, S., Akiyama, H., Onozawa, Y., and Mochida, Y. (1996) Bone Marrow Transplant. 17, 855-860
26. Nakagawara, A., and Nathan, C. F. (1983) J. Immunol. Methods 56, 261-268
27. Aebi, H. (1984) Methods Enzymol. 105, 121-126
28. De la Harpe, J., and Nathan, C. F. (1985) J. Immunol. Methods 78, 323-336
29. Kietzmann, D., Kahl, R., Muller, M., Burchardi, H., and Kettler, D. (1993) Intensive Care Med. 19, 78-81
30. Heard, S. O., Longtine, K., Toth, I., Puyana, J. C., Potenza, B., and Smyrnios, N. (1999) Anesth. Analg. 89, 353-357
31. Brummer, E., and Stevens, D. A. (1989) J. Med. Microbiol. 28, 173-181
32. Brummer, E., and Stevens, D. A. (1995) Clin. Exp. Immunol. 102, 65-70
33. Sato, K., Ito, K., Kohara, H., Yamaguchi, Y., Adachi, K., and Endo, H. (1992) Mol. Cell. Biol. 12, 2525-2533
34. Yoo, J. H., Erzurum, S. C., Hay, J. G., Lemarchand, P., and Crystal, R. G. (1994) J. Clin. Invest. 93, 297-302
35. Erzurum, S. C., Lemarchand, P., Rosenfeld, M. A., Yoo, J. H., and Crystal, R. G. (1993) Nucleic Acids Res. 21, 1607-1612
36. Erzurum, S. C., Danel, C., Gillissen, A., Chu, C. S., Trapnell, B. C., and Crystal, R. G. (1993) J. Appl. Physiol. 75, 1256-1262
37. Danel, C., Erzurum, S. C., Prayssac, P., Eissa, N. T., Crystal, R. G., Herve, P., Baudet, B., Mazmanian, M., and Lemarchand, P. (1998) Hum. Gene Ther. 9, 1487-1496
38. Stanley, E., Lieschke, G. J., Grail, D., Metcalf, D., Hodgson, G., Gall, J. A., Maher, D. W., Cebon, J., Sinickas, V., and Dunn, A. R. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5592-5596
39. Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid, A., Bronson, R. T., Dickersin, G. R., Bachurski, C. J., Mark, E. L., Whitsett, J. A., and Mulligan, R. C. (1994) Science 264, 713-716
40. LeVine, A. M., Reed, J. A., Kurak, K. E., Cianciolo, E., and Whitsett, J. A. (1999) J. Clin. Invest. 103, 563-569
41. Nishinakamura, R., Wiler, R., Dirksen, U., Morikawa, Y., Arai, K., Miyajima, A., Burdach, S., and Murray, R. (1996) J. Exp. Med. 183, 2657-2662
42. Metcalf, D., Mifsud, S., Di Rago, L., Robb, L., Nicola, N. A., and Alexander, W. (1998) Leukemia 12, 353-362
43. Kurata, S., and Yamamoto, N. (1999) J. Cell. Biochem. 76, 13-19
44. Klebanoff, S. J., and Headley, C. M. (1999) Blood 93, 350-356
45. Kazazi, F., Koehler, J. K., and Klebanoff, S. J. (1996) Free Radic. Biol. Med. 20, 813-820
46. Klebanoff, S. J., Watts, D. H., Mehlin, C., and Headley, C. M. (1999) J. Infect. Dis. 179, 653-660
47. Moriuchi, M., Moriuchi, H., Turner, W., and Fauci, A. S. (1998) J. Clin. Invest. 102, 1540-1550


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
L. A. Yeager, A. K. Chopra, and J. W. Peterson
Bacillus anthracis Edema Toxin Suppresses Human Macrophage Phagocytosis and Cytoskeletal Remodeling via the Protein Kinase A and Exchange Protein Activated by Cyclic AMP Pathways
Infect. Immun., June 1, 2009; 77(6): 2530 - 2543.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Monick, L. S. Powers, C. W. Barrett, S. Hinde, A. Ashare, D. J. Groskreutz, T. Nyunoya, M. Coleman, D. R. Spitz, and G. W. Hunninghake
Constitutive ERK MAPK Activity Regulates Macrophage ATP Production and Mitochondrial Integrity
J. Immunol., June 1, 2008; 180(11): 7485 - 7496.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. A. Tephly and A. B. Carter
Constitutive NADPH oxidase and increased mitochondrial respiratory chain activity regulate chemokine gene expression
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1143 - L1155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Monick, L. S. Powers, T. J. Gross, D. M. Flaherty, C. W. Barrett, and G. W. Hunninghake
Active ERK Contributes to Protein Translation by Preventing JNK-Dependent Inhibition of Protein Phosphatase 1
J. Immunol., August 1, 2006; 177(3): 1636 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Yoshioka, T. Kitao, T. Kishino, A. Yamamuro, and S. Maeda
Nitric oxide protects macrophages from hydrogen peroxide-induced apoptosis by inducing the formation of catalase.
J. Immunol., April 15, 2006; 176(8): 4675 - 4681.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Komuro, T. Yasuda, A. Iwamoto, and K. S. Akagawa
Catalase Plays a Critical Role in the CSF-independent Survival of Human Macrophages via Regulation of the Expression of BCL-2 Family
J. Biol. Chem., December 16, 2005; 280(50): 41137 - 41145.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. Kawamura, K. Iyonaga, H. Ichiyasu, J. Nagano, M. Suga, and Y. Sasaki
Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation
Clin. Vaccine Immunol., January 1, 2005; 12(1): 206 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pelletier, A. Bouchard, and D. Girard
In Vivo and In Vitro Roles of IL-21 in Inflammation
J. Immunol., December 15, 2004; 173(12): 7521 - 7530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. B. Carter, L. A. Tephly, S. Venkataraman, L. W. Oberley, Y. Zhang, G. R. Buettner, D. R. Spitz, and G. W. Hunninghake
High Levels of Catalase and Glutathione Peroxidase Activity Dampen H2O2 Signaling in Human Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 43 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Monick, R. K. Mallampalli, M. Bradford, D. McCoy, T. J. Gross, D. M. Flaherty, L. S. Powers, K. Cameron, S. Kelly, A. H. Merrill Jr., et al.
Cooperative Prosurvival Activity by ERK and Akt in Human Alveolar Macrophages is Dependent on High Levels of Acid Ceramidase Activity
J. Immunol., July 1, 2004; 173(1): 123 - 135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Kumar, F. J. Piedrafita, and W. F. Reynolds
Peroxisome Proliferator-activated Receptor {gamma} Ligands Regulate Myeloperoxidase Expression in Macrophages by an Estrogen-dependent Mechanism Involving the -463GA Promoter Polymorphism
J. Biol. Chem., February 27, 2004; 279(9): 8300 - 8315.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Komuro, Y. Yokota, S. Yasuda, A. Iwamoto, and K. S. Kagawa
CSF-induced and HIV-1-mediated Distinct Regulation of Hck and C/EBP{beta} Represent a Heterogeneous Susceptibility of Monocyte-derived Macrophages to M-tropic HIV-1 Infection
J. Exp. Med., August 4, 2003; 198(3): 443 - 453.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/26/24360    most recent
M102081200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komuro, I.
Right arrow Articles by Akagawa, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komuro, I.
Right arrow Articles by Akagawa, K. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement